All the global diabetes information at your fingertips.
Diabetes Scientia is an exclusive cutomised solution that delivers key information from worldclass diabetes scientific journals and medical conferences, in a simple, microlearning format.
Diabetes Scientia is an exclusive cutomised solution that delivers key information from worldclass diabetes scientific journals and medical conferences, in a simple, microlearning format.
FMedSci, FRCPath, FRCPGlas, FRSE
Professor of Metabolic Medicine at the Institute of Cardiovascular & Medical Sciences at the University of Glasgow
CBE, MB, ChB, MD, FRCP, FRCGP
Diabetes Research Centre/ Department of Health Sciences Professor of Diabetes Medicine
MD
Senior Investigator at Florida Hospital Translational Research Institute for Metabolism and Diabetes
MD, PhD,FACE
Senior Endocrinologist, Medical Director of the Obesity Clinical Program, Director of Inpatient Diabetes Program, Joslin
MD, DMSc
Head of Complications Research, Chief Physician, Steno Diabetes Center, Copenhagen, Denmark
PhD
Genetic Epidemiology and Deputy Director at Lund University Diabetes Center in Sweden, Adjunct Proffessor at Harvard University
Study from anywhere, using your device of choice.
Swift and user-friendly.
Content reviewed by peers.
Journals and congresses of exceptional quality.
There is an urgent need to develop novel strategies to treat insufficient weight loss or weight regain in post-bariatric patients. Despite the overall safety and efficacy of bariat-ric metabolic surgery (BS), outcomes vary considerably for individual patients [1]. Approximately 20–25% of patients experience considerable weight regain (WR) defined as regain of weight that occurs after achievement of an initial successful weight loss (defined as EWL% > 50%) or insuffi-cient weight loss (IWL) defined as < 50% EWL at 18 months after BS [2, 3]. As a consequence, patients may only experi-ence partial remission of comorbidities; e.g., a large num-ber of patients who experience complete T2D remission in the early period after surgery suffer a relapse on long-term follow-up [4].
